Navigation Links
DiObex in Medical Technology

DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia

...poglycemia in diabetes patients. The patent grants diobex exclusive rights to methods of reducing the risk o...s. In addition to the recently issued U.S. patent, diobex owns seven U.S. patent applications and 30 corresp...g foreign patent applications relating to DIO-901. diobex also owns or has exclusively licensed seven U.S. p...

DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug

...ditional indications under evaluation for DIO-902, diobex is well positioned to move a strong pipeline of pr...d more effective than racemic ketoconazole. About diobex DiObex, Inc. is a San Francisco-based biotechnolo... products for the treatment of metabolic diseases. diobex has two product candidates in Phase 2 clinical dev...

Diobex Announces Successful Completion of Phase 2a Trial Of DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes

...citing new drug category," commented Daniel Green, diobex President. "DIO-902 offers the possibility of ad..., M.D., Vice President of Development at DiObex. diobex plans on initiating a 16-week phase 2b dose-ranging study with DIO- 902 in mid 2007. About diobex DiObex, Inc. is a San Francisco-based biopharmac...

DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

...ations normalized during the two week treatment. diobex will conduct a multi-center, 16-week, phase 2b dos...g patients in three countries in mid-2007. About diobex DiObex, Inc. is a San Francisco-based biopharmac... products for the treatment of metabolic diseases. diobex has two products preparing to enter Phase 2b clini...
DiObex in Biological Technology

DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics

...2 is an oral, single enantiomer of ketoconazole, a common anti-fungal drug. diobex is developing DIO-902 as a novel cortisol inhibitor for treating type 2 dia...logy company developing novel products for diabetes and metabolic diseases. diobex has two product candidates in four mid-stage clinical development programs....

DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology

...ANCISCO and LUND, Sweden, March 18 /PRNewswire/ -- diobex and Camurus announced today that they have signed ...ality of life to coma and death," said David Cory, diobex CEO. "This license agreement and development progr...in-induced hypoglycemia in patients with diabetes. diobex has successfully completed three Phase 1 proof-of-...

DiObex, Inc. to Present at Merrill Lynch Global Healthcare Conference

...te presentation at the upcoming Merrill Lynch & Co, Inc. Global Pharmaceutical, Biotechnology and Medical Device Conference in New York, New York. The diobex presentation will take place on Wednesday, Feb. 6 at 10:20 a.m. at the Grand Hyatt Hotel in the Broadway room. About DiObex DiObex, Inc. is a priv...

DiObex Inc. to Present at BIO Mid-America Venture Forum

...y, September 26th at 1:30 p.m. at the Hyatt Regency Hotel in Room A. About diobex DiObex, Inc. is a San Francisco-based biotechnology company founded to develop novel products for the treatment of metabolic diseases. diobex has two product candidates in Phase 2 clinical development. DIO-901 (very l...
Other Tags
(Date:10/1/2014)... (PRWEB) October 01, 2014 Farmington ... including a redefined mission and visual identity helping ... of partnering with them to create greater benefit ... brand that focuses on empowering customers to better ... , The crown jewel of the rebrand is ...
(Date:10/1/2014)... October 01, 2014 Between 23 million ... the U.S., according to figures from the National Institutes ... Association (AARDA), and many of them have something else ... having undiagnosed celiac disease. Gluten Free Therapeutics, makers ... of undiagnosed celiac disease by publishing a series of ...
(Date:10/1/2014)... Canada (PRWEB) October 01, 2014 Anti ... removal and skin rejuvenating destination of choice, is announcing ... from October through to December. , “We’re doing this ... as possible to our top skin clinic in Toronto,” ... “We do so much at Anti Aging Clinic, including ...
(Date:10/1/2014)... Nordic Naturals is kicking off a ... The campaign—“Buy One Bottle. Help Two Heroes.”—will raise ... nonprofit organization that helps rebuild the lives of ... would otherwise face euthanasia. From October through December ... donations of Nordic Naturals omega-3s to veterans and ...
(Date:10/1/2014)... OXNARD, CA (PRWEB) October 01, 2014 ... of the Anacapa Dental Art Institute in Oxnard and ... of Bangalore providing full mouth rehabilitation training. , “Speaking ... need of these transformative procedures to get the help ... mouth rehabilitation may involve repairing previous dental work, providing ...
Breaking Medicine News(10 mins):Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5
(Date:9/30/2014)... suite of perilous threats in today,s ocean. From ... change, fragile coral ecosystems are disappearing at unprecedented ... species of corals surrounding the island of Moorea ... their tropical environment: coral guard-crabs. New research from ... Station scientist Seabird McKeon and the museum,s predoctoral ...
(Date:9/30/2014)... of The Economist,s prestigious Innovation awards 2014 will speak ... the JW Marriott Hong Kong on Friday, October 10 th ... and the lessons those hold for others. The awards, which recognises ... decade, will be presented at a ceremony in Hong ... the first time the ceremony has come to Asia ...
(Date:9/29/2014)... the exposure to tar tended to be lower for ... Similarly, exposure to nicotine tended to be lower. , ... in several countries around the world. Previous studies have ... the smoke of these cigarettes are lower than those ... in the smoke are not necessarily linked to a ...
Breaking Biology News(10 mins):Smithsonian scientists discover coral's best defender against an army of sea stars 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7Slim cigarette smokers not exposed to more harmful chemicals 2
Other Contents